A replay will be available approximately two hours following the live call for two weeks. The replay number is 888-203-1112 (USA) using passcode 6339331.
IVERIC bio is focused on the discovery and development of novel treatment options for retinal diseases with significant unmet medical needs. The Company is currently developing both therapeutic product candidates for age-related retinal diseases and gene therapy product candidates for orphan inherited retinal diseases.
Wednesday, November 4, 2020 at 11:30 AM ET
Thursday, November 5, 2020 at 5:00 PM ET
Theravance Biopharma
Theravance Biopharma (TBPH) will report its third-quarter 2020 financial results and provide a business update after the market close. An accompanying conference call and simultaneous webcast will be hosted at 5:00 p.m. ET (2:00 p.m. PT/10:00 p.m. GMT) that day.
The firm creates transformational medicines to improve the lives of patients suffering from serious inflammatory and immunological diseases. It is developing lung-selective medicines that treat respiratory disease including FDA approved YUPELRI® (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD). The Company has an economic interest in potential future payments from Glaxo Group Limited or one of its affiliates pursuant to its agreements with Innoviva Inc (INVA) relating to certain programs, including Trelegy Ellipta.
Thursday, November 5, 2020 at 8:15 AM ET
Compugen (CGEN)
Thursday, November 5, 2020 at 5:00 PM ET
Exelixis (EXEL)
Hearing from the firms themselves about their accomplishments is extremely important for shareholders and investors in general. It enables them to have their own opinions and not rely completely on other people’s opinions without having the ability to discuss them.
To read more about these firms please use the search engine at our website.
Imminent Announcements of Important Quarterly Results
Important Quarterly Results Announcements
Monday, November 2, 2020 at 8:PM ET
IVERIC bio
IVERIC bio’s (ISEE) management team will host a live conference call and webcast following the announcement to discuss the Company’s financial results and provide a general business update.
To participate in this conference call please dial 866-575-6539 (USA) or 323-794-2575 (International) using passcode 6339331. A live, listen-only, audio webcast of the conference call can be accessed at the Investors section of the IVERIC bio website at www.ivericbio.com.
Other Articles